Study of healthy adults over 20+ years reveals daily multivitamin use is not associated with mortality benefit

FHS
June 28, 2024
11:12 am

A recent study published in JAMA Network Open determined the relationship between regular multivitamin (MV) supplementation and mortality risk among United States adults.

Editas, BMS extend T cell deal; KalVista seeks partner for preclinical HAE program

Plus, news about Novo Holdings, Pepper Bio, G1 Therapeutics and Akari: Editas, Bristol Myers Squibb add two years to T cell pact: The companies are

May 2, 2024

A controversial new study examines traditional Chinese medicine’s potential cardiac benefits

A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death

October 24, 2023

AbbVie and EvolveImmune Therapeutics sign oncology collaboration

The partnership will focus on creating multispecific biologics targeting various oncology indications. Credit: afotostock via Shutterstock. AbbVie has entered into a partnership and option-to-license agreement with

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.